EcoR1 Is Launching a Second SPAC

The biopharma specialist’s hedge fund had another very strong year in 2020.

Stephen Taub March 11, 2021

Oleg Nodelman, founder of EcoR1 Capital.

(Amanda Gordon/Bloomberg)

One of the hottest health care-related hedge funds is planning to launch its second blank-check company one month after its first one closed on a merger deal.EcoR1 Capital, headed by one-time Institutional Investor Hedge Fund Rising Star Oleg Nodelman, on Tuesday said in

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.04 build:2025-12-18 Login